PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Infectious Diseases Unit, Prince Sultan Military Medical City, Riyadh, Saudi Arabia.\', \'Infectious Diseases Unit, Dhahran General Hospital, Dhahran, Saudi Arabia.\', \'Pulmonary Medicine Unit, Prince Sultan Military Medical City, Riyadh, Saudi Arabia.\', \'Infectious Disease Unit, Imam Abdulrahman Al Faisal Hospital, Riyadh, Saudi Arabia.\', \'King Faisal Specialist Hospital & Research Center, Riyadh, Saudi Arabia.\', \'Department of Endocrinology and Diabetes, Prince Sultan Military Medical City, Saudi Arabia.\', \'Infectious Diseases Unit, Prince Sultan Military Medical City, Riyadh, Saudi Arabia. Electronic address: felzein@psmmc.med.sa.\']
?:citedBy
  • -1
?:creator
?:doi
  • S1876-0341(21)00150-710.1016/j.jiph.2021.05.015
?:doi
?:hasPublicationType
?:journal
  • Journal of infection and public health
is ?:pmid of
?:pmid
?:pmid
  • 34153727
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 0.648
?:rankingScore_hIndex
  • 23
?:title
  • Efficacy of tocilizumab in patients with severe COVID-19: Survival and clinical outcomes.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all